US OptionsDetailed Quotes

LFST240719P8000

Watchlist

2.48
+0.83+50.30%

15min DelayClose Jul 19 15:59 ET

2.48High2.41Low

LifeStance Health Stock Discussion

Moomoo AI

Mar 21 08:53

LifeStance Health Group's positive outlook appears to be priced in, but its high growth potential at a fair price makes it an attractive investment. Higher cash flow is expected, potentially leading to a higher share valuation.

Is LifeStance Health Group, Inc. (NASDAQ:LFST) Potentially Undervalued?

Moomoo AI

Mar 12 08:11

LifeStance's CEO, Ken Burdick, is confident that Dr. DeLuca's skills will complement the board as they expand mental healthcare access. Dr. DeLuca is excited to join and help more patients receive personalized care.

Press Release: LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

Moomoo AI

Feb 29 04:30

LifeStance Health Group's high P/S ratio reflects market expectations of continued strong revenue growth. Investors may overpay if these expectations aren't met, but strong future revenue forecasts suggest a decrease in revenues is unlikely.

Why Investors Shouldn't Be Surprised By LifeStance Health Group, Inc.'s (NASDAQ:LFST) 32% Share Price Surge

Moomoo AI

Feb 14 08:16

Despite top line growth, LifeStance Health Group is incurring a loss of US$145m on the EBIT line. The company's balance sheet, burdened with liabilities against cash, is deemed unfit and risky.

Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt

Moomoo AI

Jan 19 08:10

CEO Ken Burdick is confident in Dr. Ramtekkar's ability to drive exceptional patient and clinical outcomes, citing his commitment to clinical excellence. Dr. Ramtekkar is excited to join LifeStance and continue setting the bar for clinical excellence in mental health.

Press Release: LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer

Moomoo AI

Jan 10 07:57

Multiple insiders selling shares could be a red flag. However, the President & COO's large sale was at a high price. High insider ownership suggests management's interest in shareholders, but lack of insider purchases doesn't instill confidence.

Insiders At LifeStance Health Group Sold US$3.8m In Stock, Alluding To Potential Weakness

Moomoo AI

Dec 6, 2023 21:36

LifeStance Health Group's higher P/S ratio is likely due to anticipation of continued robust revenue performance. Shareholders seem at ease with this P/S, confident in the company's future revenue prospects and expecting it to outperform its industry.

The Price Is Right For LifeStance Health Group, Inc. (NASDAQ:LFST)

Rivera

Mar 8, 2023 09:31

The Baam is caming here get in

$LifeStance Health(LFST.US)$

AmyNic

Mar 8, 2023 08:32

👀

$LifeStance Health(LFST.US)$

Moomoo Breakfast US

Mar 17, 2022 06:59

ColumnsTop upgrades and downgrades on 3/17

Upgrades
• $Aspen Technology(AZPN.US)$ : Loop Capital Upgrades to Buy from Hold - PT $175
• $CSX Corp(CSX.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $39 (from $37)
• $Ecolab(ECL.US)$ : Edward Jones Upgrades to Buy from Hold
• $Fortive(FTV.US)$ : Argus Upgrades to Buy from Hold - PT $68
• $Health Catalyst(HCAT.US)$ : Jefferies Upgrades To Buy From Hold - PT $28 (From $31)
• $Huntington Ingalls Industries(HII.US)$ : Vertical Research Upgra...

No comment yet